Takashi Azuma

Dr. Takashi Azuma

Department of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Science of The Total Environment
Verified
Journal Article
Closed access
Takashi AzumaTakashi Azuma
Takashi Azuma
NANatsumi Arima
Natsumi Arima
ATAi Tsukada
Ai Tsukada
SHSatoru Hirami
Satoru Hirami
RMRie Matsuoka
Rie Matsuoka
MMMikio Masada
Mikio Masada

1 March 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
Takashi AzumaTakashi Azuma
Takashi Azuma
KOKana Otomo
Kana Otomo
MKMari Kunitou
Mari Kunitou
MSMai Shimizu
Mai Shimizu
KHKaori Hosomaru
Kaori Hosomaru
THTetsuya Hayashi
Tetsuya Hayashi

1 February 2017 in Chemosphere
Verified
Journal Article
Closed access
Takashi AzumaTakashi Azuma
Takashi Azuma
MIMao Ishida
Mao Ishida
KHKanae Hisamatsu
Kanae Hisamatsu
AYAyami Yunoki
Ayami Yunoki
KOKana Otomo
Kana Otomo
YMYoshiki Mino
Yoshiki Mino

17 July 2015 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
Takashi AzumaTakashi Azuma
Takashi Azuma
HIHirotaka Ishiuchi
Hirotaka Ishiuchi
TITomomi Inoyama
Tomomi Inoyama
YTYusuke Teranishi
Yusuke Teranishi
MYMisato Yamaoka
Misato Yamaoka
YMYoshiki Mino
Yoshiki Mino

1 July 2021 in Science of The Total Environment
Verified
Journal Article
Closed access
Takashi AzumaTakashi Azuma
Takashi Azuma
THTetsuya Hayashi
Tetsuya Hayashi

7 February 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Takashi AzumaTakashi Azuma
Takashi Azuma
MUMasaru Usui
Masaru Usui
THTetsuya Hayashi
Tetsuya Hayashi
The inactivating effect of ozone (O3)-based advanced oxidation processes (AOPs) (O3/H2O2, O3/UV, and O3/UV/H2O2 systems) on antimicrobial-resistant bacteria (AMRB) and antimicrobial-susceptible bacteria (AMSB) in sewage treatment plant (STP) wastewater was investigated. The AMRB were grouped into six classes: carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E), multidrug-resistant Acinetobacter (MDRA), multidrug-resistant Pseudomonas aeruginosa (MDRP), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE); these classes constituted the World Health Organization (WHO) global priority list of AMRB. The results indicate that O3-based advanced wastewater treatment inactivated all AMRB and AMSB (>99.9%) after 10 min of treatment, and significant differences (p < 0.5) were not observed in the disinfection of AMRB and AMSB by each treatment. Altered taxonomic diversity of micro-organisms based on 16S rRNA gene sequencing via O3/UV and O3/UV/H2O2 treatment showed that advanced wastewater treatments not only inactivated AMRB but also removed antimicrobial resistance genes (AMRGs) in the wastewater. Consequently, this study recommends the use of advanced wastewater treatments for treating the STP effluent, reducing environmental pollution, and alleviating the potential hazard to human health caused by AMRB, AMSB, and infectious diseases. Overall, this study provides a new method for assessing environmental risks associated with the spread of AMRB and AMSB in aquatic environments, while keeping the water environment safe and maintaining human health.